Molecular characteristics and clinical outcomes of breast cancer with HRAS mutations. ASCO, Abst: 561 Poster: 333, 6/2022.

S Kareff, Matias Bustos, Dave S.B. Hoon, See all authors in notes

Research output: Contribution to conferenceAbstract

Original languageAmerican English
StatePublished - 2022

Cite this